PDx — Cost of Sales
GE HealthCare Technologies PDx — Cost of Sales increased by 1.2% to $406.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 38.1%, from $294.00M to $406.00M. Over 3 years (FY 2022 to FY 2025), PDx — Cost of Sales shows an upward trend with a 13.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase relative to revenue suggests margin compression due to rising input costs or manufacturing inefficiencies, while a decrease indicates improved production cost control.
Detailed definition
Includes the direct costs associated with manufacturing and distributing contrast media and diagnostic agents, such as r...
Peer comparison
Standard cost of goods sold metric found in manufacturing-heavy business segments across the medical device and pharmaceutical industries.
gehc_segment_pdx_cost_of_salesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $251.25M | $251.25M | $251.25M | $251.25M | $298.00M | $298.00M | $298.00M | $298.00M | $295.00M | $314.00M | $312.00M | $315.00M | $294.00M | $371.00M | $384.00M | $401.00M | $406.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +18.6% | +0.0% | +0.0% | +0.0% | -1.0% | +6.4% | -0.6% | +1.0% | -6.7% | +26.2% | +3.5% | +4.4% | +1.2% |
| YoY Change | — | — | — | — | +18.6% | +18.6% | +18.6% | +18.6% | -1.0% | +5.4% | +4.7% | +5.7% | -0.3% | +18.2% | +23.1% | +27.3% | +38.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is GE HealthCare Technologies's pdx — cost of sales?
- GE HealthCare Technologies (GEHC) reported pdx — cost of sales of $406.00M in Q1 2026.
- How has GE HealthCare Technologies's pdx — cost of sales changed year-over-year?
- GE HealthCare Technologies's pdx — cost of sales increased by 38.1% year-over-year, from $294.00M to $406.00M.
- What is the long-term trend for GE HealthCare Technologies's pdx — cost of sales?
- Over 3 years (2022 to 2025), GE HealthCare Technologies's pdx — cost of sales has grown at a 13.0% compound annual growth rate (CAGR), from $1.01B to $1.45B.
- What does pdx — cost of sales mean?
- The direct costs incurred to produce and deliver the goods sold by the Pharmaceutical Diagnostics segment.